Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer|November 7, 2003
Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkersMichele Follen, Frank L Meyskens, Ronald D Alvarez, et al.Cancer Letters|October 14, 2014
Ormeloxifene efficiently inhibits ovarian cancer growthDiane M Maher, Sheema Khan, Jordan L Nordquist, et al.Cancer|March 24, 2010
Cervical cancer prevention: new tools and old barriersIsabel C Scarinci, Francisco A R Garcia, Erin Kobetz, et al.Experimental Dermatology|October 1, 2019
Ex vivo culture of mouse skin activates an interleukin 1 alpha-dependent inflammatory responseHong-Ming Zhou, Radomir M Slominski, Leroy J Seymour, et al.ACS Omega|October 30, 2023
Synthesis and Antitumor Activity of Brominated-Ormeloxifene (Br-ORM) against Cervical CancerMohammed Sikander, Shabnam Malik, John Apraku, et al.Gynecologic Oncology|January 31, 2014
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tubeThomas J Herzog, Bradley J Monk, Peter G Rose, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2021
Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004Debra L Barton, Stephanie L Pugh, Patricia A Ganz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group studyCharles F Levenback, Shamshad Ali, Robert L Coleman, et al.Gynecologic Oncology|December 4, 2012
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173Robert L Coleman, Shamshad Ali, Charles F Levenback, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199Mark E Sherman, Marion Piedmonte, Phuong L Mai, et al.Pageof 3